
Rhoen Klinikum AG
XETRA:RHK

Profitability Summary
Rhoen Klinikum AG's profitability score is 49/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Score

Score
Margins
Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.
Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Earnings Waterfall
Rhoen Klinikum AG
Revenue
|
1.5B
EUR
|
Cost of Revenue
|
-530.9m
EUR
|
Gross Profit
|
1B
EUR
|
Operating Expenses
|
-970m
EUR
|
Operating Income
|
45.2m
EUR
|
Other Expenses
|
-330k
EUR
|
Net Income
|
44.9m
EUR
|
Margins Comparison
Rhoen Klinikum AG Competitors
Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
---|---|---|---|---|---|---|---|
DE |
![]() |
Rhoen Klinikum AG
XETRA:RHK
|
1.1B EUR |
66%
|
3%
|
3%
|
|
US |
![]() |
HCA Healthcare Inc
NYSE:HCA
|
83.8B USD |
85%
|
15%
|
8%
|
|
SA |
![]() |
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR |
33%
|
21%
|
21%
|
|
ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
20.7B Zac |
36%
|
12%
|
19%
|
|
ZA |
N
|
Netcare Ltd
JSE:NTC
|
17.7B Zac |
49%
|
13%
|
6%
|
|
CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
117B CNY |
50%
|
23%
|
18%
|
|
MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
60.5B MYR |
72%
|
17%
|
11%
|
|
IN |
![]() |
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
1.1T INR |
79%
|
21%
|
15%
|
|
IN |
![]() |
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1T INR |
48%
|
10%
|
6%
|
|
US |
![]() |
Tenet Healthcare Corp
NYSE:THC
|
11.5B USD |
82%
|
16%
|
15%
|
|
BR |
![]() |
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
65.9B BRL |
19%
|
15%
|
8%
|
Return on Capital
Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.




Return on Capital Comparison
Rhoen Klinikum AG Competitors
Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
---|---|---|---|---|---|---|---|---|
DE |
![]() |
Rhoen Klinikum AG
XETRA:RHK
|
1.1B EUR |
4%
|
2%
|
3%
|
3%
|
|
US |
![]() |
HCA Healthcare Inc
NYSE:HCA
|
83.8B USD |
-270%
|
10%
|
24%
|
16%
|
|
SA |
![]() |
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR |
34%
|
13%
|
16%
|
17%
|
|
ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
20.7B Zac |
29%
|
14%
|
10%
|
8%
|
|
ZA |
N
|
Netcare Ltd
JSE:NTC
|
17.7B Zac |
13%
|
5%
|
15%
|
11%
|
|
CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
117B CNY |
19%
|
12%
|
20%
|
18%
|
|
MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
60.5B MYR |
9%
|
5%
|
9%
|
7%
|
|
IN |
![]() |
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
1.1T INR |
12%
|
8%
|
13%
|
11%
|
|
IN |
![]() |
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1T INR |
19%
|
7%
|
16%
|
12%
|
|
US |
![]() |
Tenet Healthcare Corp
NYSE:THC
|
11.5B USD |
111%
|
11%
|
13%
|
10%
|
|
BR |
![]() |
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
65.9B BRL |
16%
|
4%
|
10%
|
10%
|
Free Cash Flow
Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.
If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.


